Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hyperlipoproteinemias

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 16 articles:
HTML format
Text format



Single Articles


    July 2017
  1. STAHEL P, Xiao C, Hegele RA, Lewis GF, et al
    Polygenic Risk for Hypertriglyceridemia Can Mimic a Major Monogenic Mutation.
    Ann Intern Med. 2017 Jul 25. doi: 10.7326/L17-0182.
    PubMed     Text format    


    June 2017
  2. RIDKER PM, Cook NR
    Cholesterol Evaluation in Young Adults: Absence of Clinical Trial Evidence Is Not a Reason to Delay Screening.
    Ann Intern Med. 2017;166:901-902.
    PubMed     Text format    


    May 2017
  3. PATEL KK, Taksler GB, Hu B, Rothberg MB, et al
    Prevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination Surveys.
    Ann Intern Med. 2017 May 16. doi: 10.7326/M16-2052.
    PubMed     Text format     Abstract available


    January 2017
  4. LAUFFENBURGER JC, Shrank WH, Bitton A, Franklin JM, et al
    Association Between Patient-Centered Medical Homes and Adherence to Chronic Disease Medications: A Cohort Study.
    Ann Intern Med. 2017;166:81-88.
    PubMed     Text format     Abstract available


    October 2016
  5. COOK NR, Ridker PM
    Calibration of the Pooled Cohort Equations for Atherosclerotic Cardiovascular Disease: An Update.
    Ann Intern Med. 2016 Oct 11. doi: 10.7326/M16-1739.
    PubMed     Text format     Abstract available


    March 2016
  6. SANTOS RD
    Review: PCSK9 inhibitors reduce mortality but increase neurocognitive events in hypercholesterolemia.
    Ann Intern Med. 2016;164:JC31.
    PubMed     Text format    


    January 2016
  7. TAYLOR WC
    Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular Disease.
    Ann Intern Med. 2016;164:135.
    PubMed     Text format    


  8. LLOYD-JONES DM, Goff DC, Stone NJ
    Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular Disease.
    Ann Intern Med. 2016;164:135.
    PubMed     Text format    


    November 2015
  9. SANTOS RD
    ACP Journal Club: ACC/AHA guidelines determining statin eligibility better predicted CVD than ATP-III guidelines.
    Ann Intern Med. 2015;163:JC11.
    PubMed     Text format    


    August 2015
  10. MITTLEMAN MA, Taylor WC, Smetana G, Burns RB, et al
    Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular Disease: Grand Rounds Discussion From the Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2015;163:280-90.
    PubMed     Text format     Abstract available


  11. CORNELL JE, Mulrow CD
    Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia.
    Ann Intern Med. 2015;163:242-3.
    PubMed     Text format    


  12. BATTAGGIA A, Donzelli A, Font M
    Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia.
    Ann Intern Med. 2015;163:241-2.
    PubMed     Text format    


  13. LIAKOS A, Athanasiadou E, Mainou M, Bekiari E, et al
    Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia.
    Ann Intern Med. 2015;163:241.
    PubMed     Text format    


    July 2015
  14. CAINZOS-ACHIRICA M, Martin SS, Cornell JE, Mulrow CD, et al
    PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?
    Ann Intern Med. 2015;163:64-5.
    PubMed     Text format    


    June 2015
  15. PATEL SA, Winkel M, Ali MK, Narayan KM, et al
    Cardiovascular Mortality Associated With 5 Leading Risk Factors: National and State Preventable Fractions Estimated From Survey Data.
    Ann Intern Med. 2015 Jun 30. doi: 10.7326/M14-1753.
    PubMed     Text format     Abstract available


    May 2015
  16. LUCATORTO MA, Morgan S
    Effects of nurse-managed protocols.
    Ann Intern Med. 2015;162:669.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: